Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease.

Fessel JP, Hulette C, Powell S, Roberts LJ, Zhang J
J Neurochem. 2003 85 (3): 645-50

PMID: 12694390 · DOI:10.1046/j.1471-4159.2003.01709.x

MeSH Terms (15)

Aged Aged, 80 and over Alzheimer Disease F2-Isoprostanes Female Furans Humans Isomerism Lewy Body Disease Male Multiple System Atrophy Oxidative Stress Parkinson Disease Phospholipids Substantia Nigra

Connections (2)

This publication is referenced by other Labnodes entities: